MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

Search

ResMed Inc

Fechado

SetorSaúde

257.64 -1.32

Visão Geral

Variação de preço das ações

24h

Atual

Mín

254.58

Máximo

258.88

Indicadores-chave

By Trading Economics

Rendimento

-31M

349M

Vendas

-12M

1.3B

P/E

Médio do Setor

26.391

90.831

Rendimento de Dividendos

0.87

Margem de lucro

26.096

Funcionários

10,600

EBITDA

-29M

503M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+12.77% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.87%

2.20%

Próximos Ganhos

29 de jan. de 2026

Próxima data de dividendos

19 de mar. de 2026

Próxima data de ex-dividendo

12 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-193M

38B

Abertura anterior

258.96

Fecho anterior

257.64

Sentimento de Notícias

By Acuity

24%

76%

42 / 361 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

16 de jan. de 2026, 23:29 UTC

Ações em Alta

Stocks to Watch: Atossa Therapeutics, Union Pacific

17 de jan. de 2026, 15:06 UTC

Aquisições, Fusões, Aquisições de Empresas

Trump Purchased Netflix, Warner Bonds in Days After Deal Announcement -- Update

17 de jan. de 2026, 10:30 UTC

Ganhos

Supersize CEO Pay Packages Aren't Paying Off for Shareholders -- WSJ

17 de jan. de 2026, 03:10 UTC

Aquisições, Fusões, Aquisições de Empresas

Trump Purchased Netflix, Warner Bonds In Days After Deal Announcement -- WSJ

16 de jan. de 2026, 22:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- 2nd Update

16 de jan. de 2026, 22:43 UTC

Aquisições, Fusões, Aquisições de Empresas

Union Pacific: Additional Information Requested to Be Provided to Surface Transportation Board

16 de jan. de 2026, 22:22 UTC

Aquisições, Fusões, Aquisições de Empresas

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- Update

16 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Tech, Media & Telecom Roundup: Market Talk

16 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Auto & Transport Roundup: Market Talk

16 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

16 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

16 de jan. de 2026, 21:48 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Union Pacific, Norfolk Southern Market Share Ruled as Faulty -- Market Talk

16 de jan. de 2026, 21:41 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Union Pacific, Norfolk Southern Deal Rejection Leaves Questions -- Market Talk

16 de jan. de 2026, 21:38 UTC

Aquisições, Fusões, Aquisições de Empresas

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- WSJ

16 de jan. de 2026, 21:30 UTC

Aquisições, Fusões, Aquisições de Empresas

STB: Union Pacific, Norfolk Southern Application Doesn't Include 'Projected Market Shares' as Required

16 de jan. de 2026, 21:30 UTC

Aquisições, Fusões, Aquisições de Empresas

STB: Union Pacific, Norfolk Southern Application Doesn't Include Certain Schedules, Documents Expressly Made Part of Merger Agreement

16 de jan. de 2026, 21:30 UTC

Aquisições, Fusões, Aquisições de Empresas

STB: Union Pacific, Norfolk Southern Application Doesn't Contain Certain Information Required by Regulations

16 de jan. de 2026, 21:30 UTC

Aquisições, Fusões, Aquisições de Empresas

STB: Application Rejected Without Prejudice to Union Pacific, Norfolk Southern Refiling Revised Application Remedying Deficiencies

16 de jan. de 2026, 21:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Surface Transportation Board: Union Pacific, Norfolk Southern Major Merger Application Filed Dec. 19 Incomplete

16 de jan. de 2026, 20:44 UTC

Ganhos

5 Takeaways From This Season's Wealth Management Earnings -- Barrons.com

16 de jan. de 2026, 20:42 UTC

Conversa de Mercado

Oil Futures Post Fourth Straight Weekly Gain -- Market Talk

16 de jan. de 2026, 20:28 UTC

Conversa de Mercado

U.S. Natural Gas Slips Ahead of Long Weekend -- Market Talk

16 de jan. de 2026, 19:12 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Netflix Could Comment on Structure of Warner Bid During 4Q Results -- Market Talk

16 de jan. de 2026, 18:53 UTC

Conversa de Mercado

Global Crude Supply Enough to Absorb Any Iran Disruption -- Market Talk

16 de jan. de 2026, 18:41 UTC

Conversa de Mercado

Netflix's Ad Business Seen as Primary Revenue Driver in 2026 -- Market Talk

16 de jan. de 2026, 18:31 UTC

Conversa de Mercado

U.S. Oil Rig Count Rises By 1 to 410 -- Market Talk

16 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

16 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

16 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

16 de jan. de 2026, 17:03 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

12.77% parte superior

Previsão para 12 meses

Média 294 USD  12.77%

Máximo 345 USD

Mínimo 260 USD

Com base em 11 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

11 ratings

6

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

42 / 361 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat